166 related articles for article (PubMed ID: 22749837)
1. High HPV vaccination uptake rates for adolescent girls after regional governmental funding in Shiki City, Japan.
Hayashi Y; Shimizu Y; Netsu S; Hanley S; Konno R
Vaccine; 2012 Aug; 30(37):5547-50. PubMed ID: 22749837
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada.
McClure CA; MacSwain MA; Morrison H; Sanford CJ
Vaccine; 2015 Apr; 33(15):1786-90. PubMed ID: 25731789
[TBL] [Abstract][Full Text] [Related]
3. Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark.
Widgren K; Simonsen J; Valentiner-Branth P; Mølbak K
Vaccine; 2011 Dec; 29(52):9663-7. PubMed ID: 22015392
[TBL] [Abstract][Full Text] [Related]
4. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.
Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S
Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142
[TBL] [Abstract][Full Text] [Related]
5. Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population-based survey.
Arrossi S; Maceira V; Paolino M; Sankaranarayanan R
Vaccine; 2012 Mar; 30(14):2467-74. PubMed ID: 22266289
[TBL] [Abstract][Full Text] [Related]
6. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P
Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711
[TBL] [Abstract][Full Text] [Related]
7. Acceptance and compliance with postpartum human papillomavirus vaccination.
Wright JD; Govindappagari S; Pawar N; Cleary K; Burke WM; Devine PC; Lu YS; Tsai WY; Lewin SN; Herzog TJ
Obstet Gynecol; 2012 Oct; 120(4):771-82. PubMed ID: 22996094
[TBL] [Abstract][Full Text] [Related]
8. The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval.
Martín-Merino E; Llorente-García A; Castillo Cano B; Montero Corominas D; Huerta-Álvarez C
Pharmaceut Med; 2019 Dec; 33(6):519-530. PubMed ID: 31933243
[TBL] [Abstract][Full Text] [Related]
9. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
Watson M; Shaw D; Molchanoff L; McInnes C
Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
[TBL] [Abstract][Full Text] [Related]
10. Citizen intervention in a religious ban on in-school HPV vaccine administration in Calgary, Canada.
Guichon JR; Mitchell I; Buffler P; Caplan A
Prev Med; 2013 Nov; 57(5):409-13. PubMed ID: 23769899
[TBL] [Abstract][Full Text] [Related]
11. School-based vaccination of young US males: impact of health beliefs on intent and first dose acceptance.
Rickert VI; Auslander BA; Cox DS; Rosenthal SL; Rickert JA; Rupp R; Zimet GD
Vaccine; 2014 Apr; 32(17):1982-7. PubMed ID: 24492015
[TBL] [Abstract][Full Text] [Related]
12. Utilization of administrative data to assess the association of an adolescent health check-up with human papillomavirus vaccine uptake in Germany.
Rieck T; Feig M; Deleré Y; Wichmann O
Vaccine; 2014 Sep; 32(43):5564-9. PubMed ID: 25131739
[TBL] [Abstract][Full Text] [Related]
13. HPV vaccination: vaccine acceptance, side effects and screening intentions.
Paul-Ebhohimhen V; Huc S; Tissington H; Oates K; Stark C
Community Pract; 2010 Jun; 83(6):30-3. PubMed ID: 20586376
[TBL] [Abstract][Full Text] [Related]
14. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.
van Klooster TM; Kemmeren JM; van der Maas NA; de Melker HE
Vaccine; 2011 Jun; 29(28):4601-7. PubMed ID: 21549785
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing uptake of HPV vaccination among girls in Germany.
Schülein S; Taylor KJ; König J; Claus M; Blettner M; Klug SJ
BMC Public Health; 2016 Sep; 16():995. PubMed ID: 27645711
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities.
Guerry SL; De Rosa CJ; Markowitz LE; Walker S; Liddon N; Kerndt PR; Gottlieb SL
Vaccine; 2011 Mar; 29(12):2235-41. PubMed ID: 21288799
[TBL] [Abstract][Full Text] [Related]
17. Free school-based vaccination with HPV vaccine in a Japanese city.
Fujiwara H; Suzuki M; Yoshinari T; Shiiya K
Vaccine; 2011 Sep; 29(38):6441-2. PubMed ID: 21704106
[No Abstract] [Full Text] [Related]
18. Uptake of the human papillomavirus vaccine: a review of the literature and report of a quality assurance project.
Cassidy B; Schlenk EA
J Pediatr Health Care; 2012 Mar; 26(2):92-101. PubMed ID: 22360928
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with parental intentions for male human papillomavirus vaccination: results of a national survey.
Dempsey AF; Butchart A; Singer D; Clark S; Davis M
Sex Transm Dis; 2011 Aug; 38(8):769-76. PubMed ID: 21336230
[TBL] [Abstract][Full Text] [Related]
20. Adolescent vaccine co-administration and coverage in New York City: 2007-2013.
Sull M; Eavey J; Papadouka V; Mandell R; Hansen MA; Zucker JR
Pediatrics; 2014 Dec; 134(6):e1576-83. PubMed ID: 25384490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
